Cyproheptadine Hydrochloride Tablet
Product Images NDC 42708-177

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 42708-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708-177-21 (42708 177 21 Rev 1)

42708-177-21 (42708 177 21   Rev 1)
Label for Cyproheptadine Hydrochloride Tablets USP, 4 mg, containing 21 tablets. The label indicates it is a sample not for sale, with dosage instructions to be seen in the package insert. Distributed by QPharma Inc, Cedar Knolls, NJ. The label includes storage instructions to keep the container tightly closed and out of reach of children. It is marked Rx Only.*
FDA Label Image

Structure (Stru)

Structure (Stru)
Chemical structure of Cyproheptadine Hydrochloride showing its molecular framework with attached hydrochloride (HCl). Molecular formula C21H21N·HCl and molecular weight 350.89 are indicated below the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.